First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Short Interest Down 56.2% in January

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) was the target of a significant decline in short interest in the month of January. As of January 30th, there was short interest totaling 24,107 shares, a decline of 56.2% from the January 15th total of 55,046 shares. Approximately 2.3% of the shares of the company are short sold. Based on an average daily trading volume, of 817,638 shares, the short-interest ratio is currently 0.0 days. Based on an average daily trading volume, of 817,638 shares, the short-interest ratio is currently 0.0 days. Approximately 2.3% of the shares of the company are short sold.

First Trust NYSE Arca Biotechnology Index Fund Trading Down 2.4%

FBT traded down $4.97 during trading hours on Thursday, hitting $204.96. The company’s stock had a trading volume of 89,881 shares, compared to its average volume of 313,527. The company has a 50-day simple moving average of $212.49 and a 200 day simple moving average of $194.09. The firm has a market capitalization of $215.21 million, a PE ratio of 21.72 and a beta of 0.65. First Trust NYSE Arca Biotechnology Index Fund has a fifty-two week low of $141.38 and a fifty-two week high of $224.94.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Northwestern Mutual Wealth Management Co. raised its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 4,370.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 577,231 shares of the company’s stock valued at $119,210,000 after purchasing an additional 564,319 shares in the last quarter. Stonebridge Financial Group LLC acquired a new position in First Trust NYSE Arca Biotechnology Index Fund during the 4th quarter valued at about $14,734,000. LPL Financial LLC raised its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 30.0% during the 4th quarter. LPL Financial LLC now owns 260,833 shares of the company’s stock worth $53,867,000 after buying an additional 60,187 shares in the last quarter. Janney Montgomery Scott LLC lifted its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 139.1% in the 4th quarter. Janney Montgomery Scott LLC now owns 70,054 shares of the company’s stock worth $14,468,000 after acquiring an additional 40,754 shares during the period. Finally, Ameritas Advisory Services LLC boosted its holdings in shares of First Trust NYSE Arca Biotechnology Index Fund by 12,410.9% in the fourth quarter. Ameritas Advisory Services LLC now owns 29,901 shares of the company’s stock valued at $6,175,000 after acquiring an additional 29,662 shares in the last quarter.

About First Trust NYSE Arca Biotechnology Index Fund

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.